Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-07T02:08:17.478Z Has data issue: false hasContentIssue false

Porcine models for the metabolic syndrome, digestive and bone disorders: a general overview

Published online by Cambridge University Press:  22 February 2010

J. C. Litten-Brown*
Affiliation:
Department of Agriculture, University of Reading, Earley Gate, PO Box 237, Reading, Berkshire, RG6 6AR, UK
A. M. Corson
Affiliation:
Department of Agriculture, University of Reading, Earley Gate, PO Box 237, Reading, Berkshire, RG6 6AR, UK
L. Clarke
Affiliation:
Department of Agriculture, University of Reading, Earley Gate, PO Box 237, Reading, Berkshire, RG6 6AR, UK

Abstract

The aim of this review article is to provide an overview of the role of pigs as a biomedical model for humans. The usefulness and limitations of porcine models have been discussed in terms of metabolic, cardiovascular, digestive and bone diseases in humans. Domestic pigs and minipigs are the main categories of pigs used as biomedical models. One drawback of minipigs is that they are in short supply and expensive compared with domestic pigs, which in contrast cost more to house, feed and medicate. Different porcine breeds show different responses to the induction of specific diseases. For example, ossabaw minipigs provide a better model than Yucatan for the metabolic syndrome as they exhibit obesity, insulin resistance and hypertension, all of which are absent in the Yucatan. Similar metabolic/physiological differences exist between domestic breeds (e.g. Meishan v. Pietrain). The modern commercial (e.g. Large White) domestic pig has been the preferred model for developmental programming due to the 2- to 3-fold variation in body weight among littermates providing a natural form of foetal growth retardation not observed in ancient (e.g. Meishan) domestic breeds. Pigs have been increasingly used to study chronic ischaemia, therapeutic angiogenesis, hypertrophic cardiomyopathy and abdominal aortic aneurysm as their coronary anatomy and physiology are similar to humans. Type 1 and II diabetes can be induced in swine using dietary regimes and/or administration of streptozotocin. Pigs are a good and extensively used model for specific nutritional studies as their protein and lipid metabolism is comparable with humans, although pigs are not as sensitive to protein restriction as rodents. Neonatal and weanling pigs have been used to examine the pathophysiology and prevention/treatment of microbial-associated diseases and immune system disorders. A porcine model mimicking various degrees of prematurity in infants receiving total parenteral nutrition has been established to investigate gut development, amino acid metabolism and non-alcoholic fatty liver disease. Endoscopic therapeutic methods for upper gastrointestinal tract bleeding are being developed. Bone remodelling cycle in pigs is histologically more similar to humans than that of rats or mice, and is used to examine the relationship between menopause and osteoporosis. Work has also been conducted on dental implants in pigs to consider loading; however with caution as porcine bone remodels slightly faster than human bone. We conclude that pigs are a valuable translational model to bridge the gap between classical rodent models and humans in developing new therapies to aid human health.

Information

Type
Full Paper
Copyright
Copyright © The Animal Consortium 2010
Figure 0

Table 1 A comparison of reproductive and general anatomical/physiological factors between human, swine and rats

Figure 1

Table 2 An overview of the use of the pig as a biomedical model

Figure 2

Table 3 Placental and metabolic comparisons between foetal and neonatal humans, swine and rats

Figure 3

Figure 1 Comparison of prenatal development and crown-to-rump length of human (—), pig (– -) and rat (- - - -) foetuses throughout gestation. (a) Adapted from Book and Bustad (1974) and Hill (2008). (b) Adapted from Book and Bustad (1974), and Evans and Sack (1973).

Figure 4

Figure 2 The effect of low (L) or normal (N) birth weight on the area under the curve following a glucose tolerance test (GTT) at 3, 6 and 12 months of age and during pregnancy. Values are presented as Mean ± s.e.m., L pigs are represented by black bars, N pigs by white bars. GTT: intravenous administration of 0.5 g/kg BW dextrose 40%. Data taken from Poore and Fowden, 2004a (3 and 12 months) and Corson et al., 2008b (6 months and pregnancy).

Figure 5

Table 4 A comparison of diet-induced metabolic syndrome in different breeds of pig

Figure 6

Table 5 Response to increasing dose rates of streptozotocin in juvenile pigs

Figure 7

Figure 3 The incidence and severity of diarrhoea as influenced by breast (colostrum) milk (BR), milk formula (FORM) and milk formula with probiotics (FORM+) in caesarean-delivered preterm pigs and weaned pigs orally administered either a placebo (PRO−) or probiotic (PRO+). Values are presented as means for incidence & mean ± s.e.m. for severity. FORM+ = Bifidobacterium animalis and Lactobacillus: L. acidophilus, L. casei, L. pentosus, L. plantarum. PRO+ = Bifidobacterium lactis HN019 (109 colony-forming units (cfu)/piglet per day). Caesarean-delivered preterm pigs data adapted from Siggers et al. (2008). Weaned pigs data adapted from Shu et al. (2001).